JENKINS_HEALTH_CARE_LIMIT - Accounts


Company Registration No. 06873327 (England and Wales)
JENKINS HEALTH CARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020
JENKINS HEALTH CARE LIMITED
COMPANY INFORMATION
Directors
Mr B J Jenkins
Mrs M E Jenkins
Mr T S Jenkins
Company number
06873327
Registered office
Hollins Care Centre
The Hollins
Cimla
NEATH
UK
SA11 3BQ
Auditor
Azets Audit Services
Charter Court
Phoenix Way Enterprise Park
Swansea
SA7 9FS
JENKINS HEALTH CARE LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 5
Independent auditor's report
6 - 8
Group statement of comprehensive income
9
Group balance sheet
10
Company balance sheet
11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Notes to the financial statements
15 - 26
JENKINS HEALTH CARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2020
- 1 -

The directors present the strategic report for the year ended 31 March 2020.

Fair review of the business

The Group specialises in providing high quality, mental and social care to residents over the age of 65 in a safe and comfortable environment. The Group has care homes based in Neath and Swansea.

 

The most recent Care Inspectorate Wales ("CIW") reviews were carried out in December 2019, November 2020 and December 2020 for the Group's care homes, the reports were generally positive and are available to the public via the CIW website. The reports communicate there were no non-compliance notices issued during the recent or previous inspections and action was being actively taken to attend to recommendations.

 

Average occupancy rates were marginally increased during the year, which combined with the acquisition by the Group of Cefn Lodge care home resulted in an increase in revenues for the Group during the year. The increased turnover has had a notable effect on operating profits with result of £18,235 compare to a loss in the previous year. The Group will continue to ensure high quality levels of catering, consumables and medicinal supplies are maintained for residents and as a result this has seen a marginal reduction in gross profit margin.

Key Performance Indicators
2020
2019
Variance
Avg. Occupany rate
83.5%
81.9%
Turnover
£4,330,033
£3,281,364
£1,048,669
Operating profit/(loss)
£18,235
£(249,339)
£267,574
Future developments

The Group will continue to focus on sustained occupancy rates and improving profitability whilst also endeavoring to deliver high quality care and standards of service to ensure the best possible care and living environment can be provided to the residents.

 

Environmental matters

The company recognises the importance of its environmental responsibilities and accepts that concern for the environment and all employees is an integral and fundamental part of its business strategy. The company monitors its impact on the environment and endeavours to design and implement policies and processes to reduce any damage that might be caused by the company's activities. Initiatives include the safe disposal of commercial waste, the minimisation of waste going to landfill, reducing energy consumption and the use of renewable resources where possible.

 

Employee involvement

The company involves its employees in its objectives, plans and performance and on other relevant matters of interest to employees through various communications methods and regular company meetings. The company is an equal community employer and does not discriminate in the recruitment and promotion of staff.

Principal risks and uncertainties

The principal trading risks continue to be the uncertainty surrounding Brexit and it's potential impact to supplies and care workers, then budgetary constraints on local authorities. Local authorities have a continuing policy of providing care at home wherever possible resulting in reduced referrals for residential and nursing homes. The Group seek to mitigate risks by ensuring they maintain high levels of quality and resources to increase occupancy rates.

JENKINS HEALTH CARE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 2 -
Financial risk management objectives and policies

The Group operates a number of risk management policies designed to minimise its exposure to financial risk.

 

Liquidity and cash flow risk                

The Group produces detailed management accounts and forecasts, which enable the directors to monitor the cash position and to ensure that ther is sufficient liquidity and cash flow to minimise the risk of the Group being able to pay its debts as they fall due.    

                    

Interest rate risk                

The Group utilises a number of financial instruments including bank loans and overdrafts in order to finance its operations. The primary risk faced by the Group as a result of its use of these financial instruments is interest rate risk.                

 

The bank overdraft borrowings at variable rates expose the Group to cash-flow interest risk, however the directors actively manage this risk by maintaining sufficient cash reserves within the Group to avoid using its overdraft facilities wherever possible.

 

Covid-19

  • In light of the situation arising in the UK and globally in respect of Covid-19 and the measures taken by the UK Government to contain the virus, the day to day operations of the business has been disrupted. The extent of the impact of Covid-19 is unclear and it is difficult to evaluate all of the potential implications on the local authority, residents, suppliers and the wider economy.

 

  • The directors have prepared updated and sensitised forecasts for the coming year and have taken steps to ensure the company has sufficient funding to bridge the period of disruption and to manage the company’s cash flow requirements as appropriate during this period of uncertainty, thus enabling the company to meet its obligations as they fall due.                

                

On behalf of the board

Mr B J Jenkins
Director
31 March 2021
JENKINS HEALTH CARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2020
- 3 -

The directors present their annual report and financial statements for the year ended 31 March 2020.

Principal activities

The principal activity of the group was residential activities for the elderly and disabled.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr B J Jenkins
Mrs M E Jenkins
Mr T S Jenkins
Results and dividends

The results for the year are set out on page 9.

Dividends of £100,000 (2019: £54,500) were paid during the year.

 

Going concern

These financial statements are prepared on the going concern basis. The directors have a reasonable expectation that the Group will continue in operational existence for the foreseeable future. However, the directors are aware of certain material uncertainties which may cause doubt on the Group's ability to continue as a going concern.

 

The Group is reporting a loss of £135,037 (2019: £299,500) for the year ended 31 March 2020 and at this date had net current liabilities of £686,529 (2019: £550,481). The situation arising post year end in the UK and globally in respect of Covid-19 and the measures taken by both the UK Government to contain the virus has had a significant impact on the business and nursing/care home industry in the post year end period. The Group has taken action to safeguard its operations during this period.

 

The directors have undertaken a review of the group's financial position. The directors have prepared forecasts, including a consideration of where disruption from Covid-19 continues to impact the residents and staff. The Group's nursing and care home properties have also had a formal valuations undertaken which are calculated based on a multiplier (reduced as a consequence of Covid-19) of the future anticipated EBITDA.

 

Based on the Group achieving results as set out in the forecasts and maintaining the property valuation, their bankers will support and are in the process restructuring some of the debt within the Group. The forecasts indicate, with local authority and government support to the industry, and based on the anticipated occupation levels, there is a reasonable expectation that the Group will be able to operate within its current level of agreed facilities for a period of at least 12 months from the date of approval of these financial statements.

 

The extent of any future impact of Covid-19 is unclear and it is difficult to evaluate all the potential implications on the Group's trade, residents, suppliers and the wider economy. However, after considering the above matters, and the expected continued support in the next 12 months of the Group's bankers, the directors are satisfied that it is appropriate to continue to prepare the financial statements on a going concern basis. The financial statements therefore do not include the adjustments required should the Group be unable to continue as a going concern.

 

 

JENKINS HEALTH CARE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 4 -
Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

JENKINS HEALTH CARE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 5 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

On behalf of the board
Mr B J Jenkins
Director
31 March 2021
JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 6 -
Opinion

We have audited the financial statements of Jenkins Health Care Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2020 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2020 and of the group's loss for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Emphasis of matter

We have considered the adequacy of the disclosure made in the accounting policies to the financial statements concerning the carrying value of the property as at 31 March 2020. The trading conditions, along with the other matters explained in the accounting policies, indicate the existence of a material uncertainty which may cast significant doubt about the carrying value of the nursing home. Were these key assumptions to which the accounting policies refer not be realised, the result would be a requirement to reduce the carrying value of the property. Any adjustment required would be a non-cash item. Our opinion is not modified in this respect.

Material uncertainty related to going concern

In forming our opinion, which is not modified, we have considered the adequacy of the disclosures made in note 1 of the financial statements concerning the group's ability to continue as a going concern. The conditions described in note 1 indicate the existence of a material uncertainty which may cast significant doubt about the group's ability to continue as a going concern. The financial statements do not include the adjustments that would result if the group was unable to continue as a going concern.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 7 -

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  • adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

  • the parent company financial statements are not in agreement with the accounting records and returns; or

  • certain disclosures of directors' remuneration specified by law are not made; or

  • we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: http://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 8 -

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Matthew Thomas (Senior Statutory Auditor)
for and on behalf of Azets Audit Services
31 March 2021
Statutory Auditor
Charter Court
Phoenix Way
Enterprise Park
Swansea
UK
SA7 9FS
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2020
- 9 -
2020
2019
Notes
£
£
Turnover
3
4,330,033
3,281,364
Cost of sales
(360,444)
(248,419)
Gross profit
3,969,589
3,032,945
Administrative expenses
(3,951,354)
(3,290,806)
Other operating income
-
8,522
Operating profit/(loss)
4
18,235
(249,339)
Interest receivable and similar income
1
8,742
Interest payable and similar expenses
7
(132,910)
(74,609)
Loss before taxation
(114,674)
(315,206)
Tax on loss
8
(20,363)
15,706
Loss for the financial year
(135,037)
(299,500)
Other comprehensive income
Revaluation of tangible fixed assets
(825,000)
868,440
Tax relating to other comprehensive income
150,000
(116,000)
Total comprehensive income for the year
(810,037)
452,940
Loss for the financial year is all attributable to the owners of the parent company.
JENKINS HEALTH CARE LIMITED
GROUP BALANCE SHEET
AS AT
31 MARCH 2020
31 March 2020
- 10 -
2020
2019
Notes
£
£
£
£
Fixed assets
Goodwill
10
238,696
397,803
Tangible assets
11
5,207,849
6,100,836
5,446,545
6,498,639
Current assets
Stocks
14
8,500
8,500
Debtors
15
186,610
160,274
Cash at bank and in hand
93,480
238,979
288,590
407,753
Creditors: amounts falling due within one year
16
(975,119)
(958,234)
Net current liabilities
(686,529)
(550,481)
Total assets less current liabilities
4,760,016
5,948,158
Creditors: amounts falling due after more than one year
17
(3,120,195)
(3,248,300)
Provisions for liabilities
19
(304,500)
(454,500)
Net assets
1,335,321
2,245,358
Capital and reserves
Called up share capital
20
200
200
Revaluation reserve
1,498,719
2,189,573
Profit and loss reserves
(163,598)
55,585
Total equity
1,335,321
2,245,358
The financial statements were approved by the board of directors and authorised for issue on 31 March 2021 and are signed on its behalf by:
31 March 2021
Mr B J Jenkins
Director
JENKINS HEALTH CARE LIMITED
COMPANY BALANCE SHEET
AS AT 31 MARCH 2020
31 March 2020
- 11 -
2020
2019
Notes
£
£
£
£
Fixed assets
Investments
12
1,788,854
1,788,854
Current assets
Debtors
15
-
103,869
Cash at bank and in hand
-
7,898
-
111,767
Creditors: amounts falling due within one year
16
(570,744)
(684,964)
Net current liabilities
(570,744)
(573,197)
Total assets less current liabilities
1,218,110
1,215,657
Creditors: amounts falling due after more than one year
17
(868,244)
(913,976)
Net assets
349,866
301,681
Capital and reserves
Called up share capital
20
200
200
Profit and loss reserves
349,666
301,481
Total equity
349,866
301,681

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £148,185 (2019 - £59,019 profit).

The financial statements were approved by the board of directors and authorised for issue on 31 March 2021 and are signed on its behalf by:
31 March 2021
Mr B J Jenkins
Director
Company Registration No. 06873327
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2020
- 12 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2018
200
1,452,987
393,731
1,846,918
Year ended 31 March 2019:
Loss for the year
-
-
(299,500)
(299,500)
Other comprehensive income:
Revaluation of tangible fixed assets
-
868,440
-
868,440
Tax relating to other comprehensive income
-
(116,000)
-
(116,000)
Total comprehensive income for the year
-
752,440
(299,500)
452,940
Dividends
9
-
-
(54,500)
(54,500)
Transfers of excess depreciation on revalued fixed assets
-
(15,854)
15,854
-
Balance at 31 March 2019
200
2,189,573
55,585
2,245,358
Year ended 31 March 2020:
Loss for the year
-
-
(135,037)
(135,037)
Other comprehensive income:
Revaluation of tangible fixed assets
-
(825,000)
-
(825,000)
Tax relating to other comprehensive income
-
150,000
-
150,000
Total comprehensive income for the year
-
(675,000)
(135,037)
(810,037)
Dividends
9
-
-
(100,000)
(100,000)
Transfers of excess depreciation on revalued fixed assets
-
(15,854)
15,854
-
Balance at 31 March 2020
200
1,498,719
(163,598)
1,335,321
JENKINS HEALTH CARE LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2020
- 13 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2018
200
296,962
297,162
Year ended 31 March 2019:
Profit and total comprehensive income for the year
-
59,019
59,019
Dividends
9
-
(54,500)
(54,500)
Balance at 31 March 2019
200
301,481
301,681
Year ended 31 March 2020:
Profit and total comprehensive income for the year
-
148,185
148,185
Dividends
9
-
(100,000)
(100,000)
Balance at 31 March 2020
200
349,666
349,866
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2020
- 14 -
2020
2019
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from/(absorbed by) operations
22
201,470
(74,511)
Interest paid
(132,910)
(74,609)
Income taxes (paid)/refunded
(91,159)
54,013
Net cash outflow from operating activities
(22,599)
(95,107)
Investing activities
Purchase of intangible assets
-
(335,000)
Purchase of tangible fixed assets
(834)
(857,454)
Proceeds from other investments and loans
-
334,990
Interest received
1
8,742
Net cash used in investing activities
(833)
(848,722)
Financing activities
Repayment of bank loans
(131,316)
1,099,955
Dividends paid to equity shareholders
(100,000)
(54,500)
Net cash (used in)/generated from financing activities
(231,316)
1,045,455
Net (decrease)/increase in cash and cash equivalents
(254,748)
101,626
Cash and cash equivalents at beginning of year
149,492
47,866
Cash and cash equivalents at end of year
(105,256)
149,492
Relating to:
Cash at bank and in hand
93,480
238,979
Bank overdrafts included in creditors payable within one year
(198,736)
(89,487)
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2020
- 15 -
1
Accounting policies
Company information

Jenkins Health Care Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Hollins Care Centre, The Hollins, Cimla, NEATH, UK, SA11 3BQ.

 

The group consists of Jenkins Health Care Limited and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

  • Section 4 ‘Statement of Financial Position’ – Reconciliation of the opening and closing number of shares;

  • Section 7 ‘Statement of Cash Flows’ – Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’ – Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

  • Section 33 ‘Related Party Disclosures’.

The consolidated financial statements incorporate those of Jenkins Health Care Limited and all of its subsidiaries (ie entities that the group controls through its power to govern the financial and operating policies so as to obtain economic benefits). Subsidiaries acquired during the year are consolidated using the merger method.

 

All financial statements are made up to 31 March 2020. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

 

 

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
1
Accounting policies
(Continued)
- 16 -
1.2
Going concern

These financial statements are prepared on the going concern basis. The directors have a reasonable expectation that the Group will continue in operational existence for the foreseeable future. However, the directors are aware of certain material uncertainties which may cause doubt on the Group's ability to continue as a going concern.

 

The Group is reporting a loss of £135,037 (2019: £299,500) for the year ended 31 March 2020 and at this date had net current liabilities of £686,529 (2019: £550,481). The situation arising post year end in the UK and globally in respect of Covid-19 and the measures taken by both the UK Government to contain the virus has had a significant impact on the business and nursing/care home industry in the post year end period. The Group has taken action to safeguard its operations during this period.

 

The directors have undertaken a review of the group's financial position. The directors have prepared forecasts, including a consideration of where disruption from Covid-19 continues to impact the residents and staff. The Group's nursing and care home properties have also had a formal valuations undertaken which are calculated based on a multiplier (reduced as a consequence of Covid-19) of the future anticipated EBITDA.

 

Based on the Group achieving results as set out in the forecasts and maintaining the property valuation, their bankers will support and are in the process restructuring some of the debt within the Group. The forecasts indicate, with local authority and government support to the industry, and based on the anticipated occupation levels, there is a reasonable expectation that the Group will be able to operate within its current level of agreed facilities for a period of at least 12 months from the date of approval of these financial statements.

 

The extent of any future impact of Covid-19 is unclear and it is difficult to evaluate all the potential implications on the Group's trade, residents, suppliers and the wider economy. However, after considering the above matters, and the expected continued support in the next 12 months of the Group's bankers, the directors are satisfied that it is appropriate to continue to prepare the financial statements on a going concern basis. The financial statements therefore do not include the adjustments required should the Group be unable to continue as a going concern.

 

1.3
Turnover

Turnover represents amounts receivable for care and nursing services provided during the year.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% straight line
Fixtures, fittings and equipment
15% reducing balance
Motor vehicles
25% reducing balance
1.5
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
1
Accounting policies
(Continued)
- 17 -

 

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and net realisable value after making due provision for any slow moving or obsolete items.

1.7
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 18 -
2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Goodwill

Determining whether goodwill is impaired requires an estimation of the value in use of the cash generating units to which goodwill has been allocated. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. The carrying amount of goodwill at the reporting end date is included in the relevant note to the accounts.

 

Property carrying values

The trading along with Covid-19 and other matters explained in the accounting policies to the financial statements, indicate the uncertainty with regards the valuation estimation to the carrying value of the care homes. All property is currently carried at latest available formal valuations obtained by the directors less accumulated depreciation where applicable.

3
Turnover and other revenue
2020
2019
£
£
Turnover analysed by class of business
Residential care services
4,330,033
3,281,364
2020
2019
£
£
Other significant revenue
Interest income
1
8,742
4
Operating profit/(loss)
2020
2019
£
£
Operating profit/(loss) for the year is stated after charging:
Depreciation of owned tangible fixed assets
68,821
110,203
Amortisation of intangible assets
159,107
125,607
Operating lease charges
7,199
10,935
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 19 -
5
Auditor's remuneration
2020
2019
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
2,500
1,000
Audit of the financial statements of the company's subsidiaries
11,000
4,000
13,500
5,000
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2020
2019
2020
2019
Number
Number
Number
Number
Administrative, care and support staff
160
124
-
-

Their aggregate remuneration comprised:

Group
Company
2020
2019
2020
2019
£
£
£
£
Wages and salaries
3,140,862
2,511,846
-
-
Pension costs
22,096
17,555
-
-
3,162,958
2,529,401
-
-
7
Interest payable and similar expenses
2020
2019
£
£
Interest on bank overdrafts and loans
132,910
74,609
8
Taxation
2020
2019
£
£
Current tax
UK corporation tax on profits for the current period
20,363
-
Adjustments in respect of prior periods
-
(15,706)
Total current tax
20,363
(15,706)
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
8
Taxation
(Continued)
- 20 -

The actual charge/(credit) for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:

2020
2019
£
£
Loss before taxation
(114,674)
(315,206)
Expected tax credit based on the standard rate of corporation tax in the UK of 19.00% (2019: 19.00%)
(21,788)
(59,889)
Tax effect of expenses that are not deductible in determining taxable profit
7,596
914
Unutilised tax losses carried forward
-
10,019
Adjustments in respect of prior years
-
(15,706)
Amortisation and Depreciation add back
36,575
51,389
Capital allowances
(2,020)
(2,433)
Taxation charge/(credit)
20,363
(15,706)

In addition to the amount charged to the profit and loss account, the following amounts relating to tax have been recognised directly in other comprehensive income:

2020
2019
£
£
Deferred tax arising on:
Revaluation of property
(150,000)
116,000
9
Dividends
2020
2019
£
£
Final paid to directors
100,000
54,500
10
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 April 2019 and 31 March 2020
1,691,070
Amortisation and impairment
At 1 April 2019
1,293,267
Amortisation charged for the year
159,107
At 31 March 2020
1,452,374
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
10
Intangible fixed assets
(Continued)
- 21 -
Carrying amount
At 31 March 2020
238,696
At 31 March 2019
397,803
The company had no intangible fixed assets at 31 March 2020 or 31 March 2019.
11
Tangible fixed assets
Group
Freehold land and buildings
Fixtures, fittings and equipment
Motor vehicles
Total
£
£
£
£
Cost or valuation
At 1 April 2019
6,175,000
959,604
19,949
7,154,553
Additions
-
834
-
834
Revaluation
(825,000)
-
-
(825,000)
At 31 March 2020
5,350,000
960,438
19,949
6,330,387
Depreciation and impairment
At 1 April 2019
108,000
925,769
19,948
1,053,717
Depreciation charged in the year
57,000
11,821
-
68,821
At 31 March 2020
165,000
937,590
19,948
1,122,538
Carrying amount
At 31 March 2020
5,185,000
22,848
1
5,207,849
At 31 March 2019
6,067,000
33,835
1
6,100,836
The company had no tangible fixed assets at 31 March 2020 or 31 March 2019.

Certain freehold and leasehold land and buildings were valued on an open market basis by Pinders and Sanderson Weatherall, both firms of independent Chartered Surveyors. The directors have considered the carrying value and do not consider it to be materially different to these valuations.

If revalued assets were stated on an historical cost basis rather than a fair value basis, the total amounts included would have been as follows:

Group
Company
2020
2019
2020
2019
£
£
£
£
Cost
3,847,258
3,847,258
-
-
Accumulated depreciation
(474,872)
(397,927)
-
-
Carrying value
3,372,386
3,449,331
-
-
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
11
Tangible fixed assets
(Continued)
- 22 -

 

12
Fixed asset investments
Group
Company
2020
2019
2020
2019
Notes
£
£
£
£
Investments in associates
-
-
1,788,854
1,788,854

 

Movements in fixed asset investments
Company
Shares in group undertakings and participating interests
£
Cost or valuation
At 1 April 2019 and 31 March 2020
1,788,854
Carrying amount
At 31 March 2020
1,788,854
At 31 March 2019
1,788,854
13
Subsidiaries

Details of the company's subsidiaries at 31 March 2020 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Cefn Lodge Limited
1
Ordinary
100.00
Cherish Care Homes (Wales) Limited
1
Ordinary
100.00
Saint Camillus Limited
1
Ordinary
100.00

1. Registered Office: Hollins Care Centre, The Hollins, Cimla, Neath, UK. SA11 3BQ.

 

14
Stocks
Group
Company
2020
2019
2020
2019
£
£
£
£
Medication, food and consumables
8,500
8,500
-
-
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 23 -
15
Debtors
Group
Company
2020
2019
2020
2019
Amounts falling due within one year:
£
£
£
£
Trade debtors
95,451
69,115
-
-
Amounts owed by group undertakings
-
-
-
103,869
Other debtors
91,159
91,159
-
-
186,610
160,274
-
103,869
16
Creditors: amounts falling due within one year
Group
Company
2020
2019
2020
2019
Notes
£
£
£
£
Bank loans and overdrafts
18
550,057
444,019
49,968
48,000
Trade creditors
74,845
64,124
-
-
Corporation tax payable
20,363
91,159
-
-
Other taxation and social security
45,581
109,414
-
-
Other creditors
202,005
207,920
520,776
636,964
Accruals and deferred income
82,268
41,598
-
-
975,119
958,234
570,744
684,964
17
Creditors: amounts falling due after more than one year
Group
Company
2020
2019
2020
2019
Notes
£
£
£
£
Bank loans and overdrafts
18
3,120,195
3,248,300
868,244
913,976
Amounts included above which fall due after five years are as follows:
Payable by instalments
668,372
1,664,683
668,372
721,976
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 24 -
18
Loans and overdrafts
Group
Company
2020
2019
2020
2019
£
£
£
£
Bank loans
3,471,516
3,602,832
918,212
961,976
Bank overdrafts
198,736
89,487
-
-
3,670,252
3,692,319
918,212
961,976
Payable within one year
550,057
444,019
49,968
48,000
Payable after one year
3,120,195
3,248,300
868,244
913,976

The long-term loans are secured by fixed and floating charges over all property and assets of the Group.

Interest is charged on bank loans at variable rates and are repayable in more than 5 years by regular monthly repayments.

19
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
2020
2019
Group
£
£
Accelerated capital allowances
6,500
6,500
Revaluations
298,000
448,000
304,500
454,500
The company has no deferred tax assets or liabilities.
Group
Company
2020
2020
Movements in the year:
£
£
Liability at 1 April 2019
454,500
-
Credit to equity
(150,000)
-
Liability at 31 March 2020
304,500
-

 

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 25 -
20
Share capital
Group and company
2020
2019
Ordinary share capital
£
£
Issued and fully paid
152 Ordinary A of £1 each
152
152
24 Ordinary B of £1 each
24
24
12 Ordinary C of £1 each
12
12
12 Ordinary D of £1 each
12
12
200
200

 

21
Controlling party

The company is controlled by the director Mrs M Jenkins who owns the majority of share capital.

22
Cash generated from/(absorbed by) group operations
2020
2019
£
£
Loss for the year after tax
(135,037)
(299,501)
Adjustments for:
Taxation charged/(credited)
20,363
(15,706)
Finance costs
132,910
74,609
Investment income
(1)
(8,742)
Amortisation and impairment of intangible assets
159,107
125,607
Depreciation and impairment of tangible fixed assets
68,821
110,203
Movements in working capital:
(Increase)/decrease in debtors
(26,336)
44,380
Decrease in creditors
(18,357)
(105,361)
Cash generated from/(absorbed by) operations
201,470
(74,511)
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2020
- 26 -
23
Analysis of changes in net debt - group
1 April 2019
Cash flows
31 March 2020
£
£
£
Cash at bank and in hand
238,979
(145,499)
93,480
Bank overdrafts
(89,487)
(109,249)
(198,736)
149,492
(254,748)
(105,256)
Borrowings excluding overdrafts
(3,602,832)
131,316
(3,471,516)
(3,453,340)
(123,432)
(3,576,772)
2020-03-312019-04-01falseCCH SoftwareCCH Accounts Production 2020.310Mr B J JenkinsMrs M E JenkinsMr T S Jenkins068733272019-04-012020-03-3106873327bus:Director12019-04-012020-03-3106873327bus:Director22019-04-012020-03-3106873327bus:Director32019-04-012020-03-3106873327bus:RegisteredOffice2019-04-012020-03-3106873327bus:Consolidated2020-03-31068733272020-03-31068733272019-03-3106873327core:CurrentFinancialInstrumentscore:WithinOneYear2020-03-3106873327core:CurrentFinancialInstrumentscore:WithinOneYear2019-03-3106873327core:Non-currentFinancialInstrumentscore:AfterOneYear2020-03-3106873327core:Non-currentFinancialInstrumentscore:AfterOneYear2019-03-3106873327core:CurrentFinancialInstruments2020-03-3106873327core:CurrentFinancialInstruments2019-03-3106873327core:ShareCapital2020-03-3106873327core:ShareCapital2019-03-31068733272018-04-012019-03-3106873327core:LandBuildingscore:OwnedOrFreeholdAssets2019-04-012020-03-3106873327core:FurnitureFittings2019-04-012020-03-3106873327core:MotorVehicles2019-04-012020-03-3106873327core:Subsidiary12019-04-012020-03-3106873327core:Subsidiary22019-04-012020-03-3106873327core:Subsidiary32019-04-012020-03-3106873327core:Subsidiary112019-04-012020-03-3106873327core:Subsidiary222019-04-012020-03-3106873327core:Subsidiary332019-04-012020-03-3106873327core:Non-currentFinancialInstruments2020-03-3106873327core:Non-currentFinancialInstruments2019-03-3106873327bus:PrivateLimitedCompanyLtd2019-04-012020-03-3106873327bus:FRS1022019-04-012020-03-3106873327bus:Audited2019-04-012020-03-3106873327bus:ConsolidatedGroupCompanyAccounts2019-04-012020-03-3106873327bus:FullAccounts2019-04-012020-03-31xbrli:purexbrli:sharesiso4217:GBP